Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Abiomed Inc (ABMD)

Abiomed Inc (ABMD)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 8,009,947
  • Shares Outstanding, K 45,377
  • Annual Sales, $ 769,430 K
  • Annual Income, $ 259,020 K
  • 60-Month Beta 0.41
  • Price/Sales 10.54
  • Price/Cash Flow 44.69
  • Price/Book 8.09

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/19
See More
  • Average Estimate 0.93
  • Number of Estimates 6
  • High Estimate 1.01
  • Low Estimate 0.86
  • Prior Year 0.81
  • Growth Rate Est. (year over year) +14.81%

Price Performance

See More
Period Period Low Period High Performance
1-Month
155.02 +12.64%
on 10/10/19
196.49 -11.14%
on 09/20/19
-16.06 (-8.42%)
since 09/18/19
3-Month
155.02 +12.64%
on 10/10/19
285.77 -38.90%
on 07/31/19
-88.16 (-33.55%)
since 07/18/19
52-Week
155.02 +12.64%
on 10/10/19
427.70 -59.17%
on 11/07/18
-212.02 (-54.84%)
since 10/18/18

Most Recent Stories

More News
Top 5 Companies in the Health Care Equipment Industry with the Best Relative Performance (ABMD , DXCM , VAR , ABT , DHR )

Below are the top five companies in the Health Care Equipment industry as measured by relative performance. This analysis was compiled based on yesterday's trading activity as we search for stocks that...

ABMD : 175.24 (-0.73%)
DXCM : 156.89 (+0.14%)
VAR : 114.68 (+0.49%)
Shares of Inogen Inc Rank the Highest in Terms of Relative Performance in the Health Care Equipment Industry (INGN , WMGI , ABMD , GKOS , IART )

Below are the top five companies in the Health Care Equipment industry as measured by relative performance. This analysis was compiled based on yesterday's trading activity as we search for stocks that...

ABMD : 175.24 (-0.73%)
INGN : 49.07 (-0.65%)
WMGI : 20.86 (-0.29%)
Shares of Nevro Corp Rank the Highest in Terms of Relative Performance in the Health Care Equipment Industry (NVRO , ABMD , IART , DHR , BAX )

Below are the top five companies in the Health Care Equipment industry as measured by relative performance. This analysis was compiled based on yesterday's trading activity as we search for stocks that...

ABMD : 175.24 (-0.73%)
IART : 62.67 (+1.15%)
NVRO : 85.02 (-0.46%)
Abiomed Second Quarter Fiscal 2020 Earnings and Conference Call Notification

Abiomed, Inc. (NASDAQ: ABMD) announced that on Thursday, October 31, 2019, the Company will release financial results for the second quarter of fiscal 2020. The Company will host a conference call to discuss...

ABMD : 175.24 (-0.73%)
Abiomed Inc Falls 2.90% on Heavy Volume: Watch For Potential Rebound

Abiomed Inc (NASDAQ:ABMD) traded in a range yesterday that spanned from a low of $158.45 to a high of $164.38. Yesterday, the shares fell 2.9%, which took the trading range below the 3-day low of $159.40...

ABMD : 175.24 (-0.73%)
AngioDynamics Boosts VIT Product Portfolio With New Buyout

AngioDynamics (ANGO) is likely to see an expansion of its already existing VIT product portfolio with the buyout of Eximo Medical.

ABMD : 175.24 (-0.73%)
ANGO : 14.69 (-2.13%)
ARAY : 2.66 (+3.91%)
AVNS : 40.38 (+2.38%)
MONDAY DEADLINE ALERT: The Schall Law Firm Announces it is Investigating Claims Against Abiomed, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Abiomed, Inc. ("Abiomed" or "the Company") (NASDAQ: ABMD) for violations...

ABMD : 175.24 (-0.73%)
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of ABMD, EVH, WTRH and MYGN

The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. If you suffered a loss you have until the lead plaintiff deadline to request...

ABMD : 175.24 (-0.73%)
EVH : 7.46 (-1.06%)
WTRH : 0.61 (-1.61%)
MYGN : 30.75 (+1.08%)
Abiomed Announces 1,000th Patient Treated with Impella in Japan

Abiomed (NASDAQ: ABMD), a leading provider of breakthrough heart support technologies, announces the 1,000th patient has been treated with the Impella heart pump in Japan. The Impella 2.5 and Impella 5.0...

ABMD : 175.24 (-0.73%)
ROSEN, A LEADING LAW FIRM, Reminds Abiomed, Inc. Investors of Important October 7th Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $100K to Contact the Firm - ABMD

Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Abiomed, Inc. (NASDAQ: ABMD) from January 31, 2019 through July 31, 2019, inclusive (the "Class Period") of the...

ABMD : 175.24 (-0.73%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Strong. Long term indicators fully support a continuation of the trend.

See More Share

Trade ABMD with:

Business Summary

Abiomed, Inc. is a provider of mechanical circulatory support devices and offers a continuum of care to heart failure patients. The Company develops, manufactures and markets proprietary products that are designed to enable the heart to rest, heal and recover by improving blood flow and/or performing...

See More

Key Turning Points

2nd Resistance Point 180.17
1st Resistance Point 178.35
Last Price 175.24
1st Support Level 175.45
2nd Support Level 174.37

See More

52-Week High 427.70
Fibonacci 61.8% 323.54
Fibonacci 50% 291.36
Fibonacci 38.2% 259.18
Last Price 175.24
52-Week Low 155.02

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar